Results 151 to 160 of about 148,003 (191)

Revisiting the FAITH Trial: A Secondary Analysis Yielding Novel Insights with the Win Ratio. [PDF]

JB JS Open Access
Bzovsky S, O'Hara NN, Slobogean GP, Sprague S, Axelrod DE, Hoit G, Pannozzo K, Bhandari M, Swiontkowski M, Schemitsch E, Poolman RW, FAITH Investigators .   +11 more
europepmc   +1 more source

Infection and Nonunion Rates in Open Fractures: Description of 6,042 Fractures from the FLOW and PREP-IT Trials. [PDF]

J Bone Joint Surg Am
Natoli RM, Marchand LS, Bzovsky S, Hagen JE, Gage MJ, Stennett CA, O'Hara NN, Jeray KJ, Petrisor B, Sprague S, Slobogean GP, the FLOW Investigators , the PREP-IT Investigators , the FLOW Investigators and the PREP-IT Investigators .   +13 more
europepmc   +1 more source

Transcriptomic profiling during normothermic machine perfusion of human kidneys reveals a pro-inflammatory cellular landscape and gene expression signature associated with severe ischemia-reperfusion injury and delayed graft function. [PDF]

Front Immunol
Spiers HVM, Hosgood SA, Larraz M, Stadler LJK, Zhai Y, Moon H, MacMillan S, Paterson A, Nicholson ML, Mohorianu I, Kosmoliaptsis V.   +10 more
europepmc   +1 more source

Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals.

J Clin Endocrinol Metab
Lao Q, Schulman A, Kulkarni S, Kollender S, Bick D, Moon A, Burkardt D, Merke DP.   +7 more
europepmc   +1 more source

Policies to promote affordability and access across the life cycle of costly new drugs.

BMJ
Kruja K, Mestre-Ferrandiz J, Hopkins MM, Ryll B, Kalo Z, Moon S.   +5 more
europepmc   +1 more source